Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06363929 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Neonatal Hyperinsulinism
A clinical trial, sponsored by MemorialCare Health System.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06363929 is a clinical trial that was terminated before completion, run by MemorialCare Health System. The registered enrollment target is 1 participants.
The verdict
NCT06363929 was terminated before completion, sponsored by MemorialCare Health System.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by glucometer, the investigators will also record the continuous glucose monitor sugar. Additionally, if the continuous glucose monitor alarms for a low sugar or an impending low sugar, the investigators will check the blood sugar by glucometer and, if verified to be low, treat the low blood sugar accordingly.
Interventions
- DEVICE Dexcom G6 continuous glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06363929
The ClinicalTrials.gov registry entry for NCT06363929 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G6 continuous glucose monitor is the first listed.
NCT06363929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06363929 about?
NCT06363929 is a clinical study titled "Continuous Glucose Monitoring in Neonatal Hyperinsulinism". The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by gl...
What is the current status of trial NCT06363929?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2023-06-01. Estimated completion is 2025-09-22.
What interventions are being tested in trial NCT06363929?
The interventions under investigation include: Dexcom G6 continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT06363929?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.